85 related articles for article (PubMed ID: 8998787)
1. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Perrone Filardi P; Chiariello M
Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
[No Abstract] [Full Text] [Related]
2. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
Krumenacker M; Roland E
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
[TBL] [Abstract][Full Text] [Related]
3. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
Specchia G; Marsico F; Micheletti T; Bona M
Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
[No Abstract] [Full Text] [Related]
4. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
5. Pinacidil but not nicorandil opens ATP-sensitive K+ channels and protects against simulated ischemia in rabbit myocytes.
Critz SD; Liu GS; Chujo M; Downey JM
J Mol Cell Cardiol; 1997 Apr; 29(4):1123-30. PubMed ID: 9160864
[TBL] [Abstract][Full Text] [Related]
6. Effects of nicorandil on large epicardial coronary artery in conscious dogs.
Yamada A; Tomoike H; Hayashi Y; Nishijima H; Nakamura M
Arzneimittelforschung; 1987 Nov; 37(11):1252-5. PubMed ID: 2964242
[TBL] [Abstract][Full Text] [Related]
7. [K-channel activators and cardioprotection].
Specchia G; Marsico F; Laudisa ML
Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
[TBL] [Abstract][Full Text] [Related]
8. [Potassium agonists].
Hellwig B
Med Monatsschr Pharm; 1994 Jun; 17(6):164-7. PubMed ID: 8052166
[No Abstract] [Full Text] [Related]
9. Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil.
Zhang S; Sakai K; Hasuo H; Furuta K; Ureshino H; Shibata O; Sumikawa K
Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):115-27. PubMed ID: 10850375
[TBL] [Abstract][Full Text] [Related]
10. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
Suryapranata H
Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of various ATP-sensitive potassium channel openers.
Grover GJ
Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
[No Abstract] [Full Text] [Related]
12. Relationship of severity of myocardial stunning to ATP dependent potassium channel modulation.
Warltier DC; Auchampach JA; Gross GJ
J Card Surg; 1993 Mar; 8(2 Suppl):279-83. PubMed ID: 8461517
[TBL] [Abstract][Full Text] [Related]
13. Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil.
Purcell H; Fox K
Br J Clin Pract; 1993; 47(3):150-4. PubMed ID: 8347442
[TBL] [Abstract][Full Text] [Related]
14. Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia.
Miyazaki T; Moritani K; Miyoshi S; Asanagi M; Zhao LS; Mitamura H; Ogawa S
J Cardiovasc Pharmacol; 1995 Dec; 26(6):949-56. PubMed ID: 8606533
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of bolus nicorandil compared with nitroglycerin.
Utoh J; Miyauchi Y; Goto H; Obayashi H; Hirata T
Am J Emerg Med; 1995 Sep; 13(5):610-2. PubMed ID: 7662070
[No Abstract] [Full Text] [Related]
16. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J
Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
Knight C; Purcell H; Fox K
Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():229-36. PubMed ID: 7647027
[TBL] [Abstract][Full Text] [Related]
18. Potassium channel activators in vasospastic angina.
Lablanche JM; Bauters C; McFadden EP; Quandalle P; Bertrand ME
Eur Heart J; 1993 Jul; 14 Suppl B():22-4. PubMed ID: 8370368
[TBL] [Abstract][Full Text] [Related]
19. Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
Yamazaki J; Ohsawa H; Uchi T; Iida M; Nakano H; Hosoi H; Morishita T; Yabe Y; Koyama N; Komatsu H
Eur J Clin Pharmacol; 1993; 44(3):211-7. PubMed ID: 8491233
[TBL] [Abstract][Full Text] [Related]
20. Nicorandil improves ischemic changes in epicardial ECG during short-term coronary occlusion by opening ATP-sensitive potassium channels in pigs.
Takaoka A; Nakae I; Liu Q; Yamamoto K; Ito M; Kinoshita M
Cardiovasc Drugs Ther; 1997 Dec; 11(6):757-66. PubMed ID: 9512871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
